home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/daeadb2a-5e52-43f3-81dd-64fc41f1ab64_F_3441_CPHI20_Whitepaper_Finished_Formulation.pdf
whitepaper
SHARESHARESHARE
PIPELINES AND PATIENTS DRIVE FINISHED DOSAGE OPPORTUNITIES
Efforts to ease patient burden with multi-API products and the increasing number of candidate products with low bioavailability are creating opportunities for contract manufacturing and development organizations (CDMOs) to create value with innovative, but complex, finished dosage formulations. Providing patients with solutions that allow them to dose less frequently and reduce complexity are a major selling point, CDMOs say. The emergence of smaller-volume products is creating practical challenges, however, for process design and scale-up. DOWNLOAD